Trials / Sponsors / Resolve Therapeutics
Resolve Therapeutics
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of RSLV-132 in Females With Sjögren's Disease Primary Sjögren Syndrome | Phase 2 | 2024-12-01 |
| Completed | Phase 2 Study of RSLV-132 in Subjects With Long COVID Post-acute Corona Virus 19 (COVID-19) (Long COVID) | Phase 2 | 2021-06-25 |
| Completed | A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome Sjogren's Syndrome | Phase 2 | 2017-02-01 |
| Completed | A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 2 | 2016-01-03 |
| Completed | Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2014-07-01 |